News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
MaaT Pharma Announces Update on U.S. FDA Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease
Thursday, August 11, 2022MaaT Pharma a French clinicalstage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM MET dedicated to improving survival outcomes for patients with cancer today announced that it received a communication from the US Food an...
Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
Wednesday, August 10, 2022Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee VRBPAC of the US Food and Drug Administration FDA will hold a meeting on September to review data supporting the biologics license applicat...
Genomind Completes Integration with Epic with support from Parkview Physicians Group
Wednesday, August 10, 2022Genomind a provider of genetic testing and population health management solutions for medication management has partnered with Parkview Physicians Group Psychiatry in Fort Wayne Indiana to complete an interface for laboratory orders and results with...
CYTENA Unveils New Generation of B.SIGHT, a Fully Automated Single-Cell Dispenser for Microorganisms
Tuesday, August 09, 2022CYTENA a BICO group company a leading provider of highprecision instruments for handling biological cells has launched a new instrument to streamline singlecell isolation in microbiology research The next generation BSIGHT is taking the companys auto...
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
Tuesday, August 09, 2022Pfizer Inc and Valneva SE announced the initiation of a Phase clinical study Vaccine Against Lyme for Outdoor Recreationists VALOR NCT to investigate the efficacy safety and immunogenicity of their investigational Lyme disease vaccine candidate VLA...
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel
Friday, August 05, 2022Moberg Pharma AB has signed a distribution agreement with Padagis Israel Agencies Ltd for MOB in Israel and the Palestinian territories Under the agreement Padagis is granted exclusive rights to market and sell MOB in Israel and the Palestinian terri...
InvoX Pharma Extends Tender Offer to Acquire F-star Therapeutics, Inc.
Friday, August 05, 2022InvoX Pharma Limited a wholly owned subsidiary of Sino Biopharmaceutical Limited focused on research and development RD and business development activities outside of China and Fstar Therapeutics Inc a clinicalstage biopharmaceutical company pioneeri...
PolyPid Announces Exclusive Licensing Agreement with ADVANZ PHARMA for the Commercialization of D-PLEX₁₀₀ in Europe
Thursday, August 04, 2022PolyPid Ltd a latestage biopharma company aiming to improve surgical outcomes today announced that it has entered into an exclusive licensing agreement with ADVANZ PHARMA Corp a UKbased global specialty and hospital pharmaceutical company for the com...
Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab
Thursday, August 04, 2022Kiniksa Pharmaceuticals Ltd a biopharmaceutical company with a portfolio of assets designed to modulate immunological pathways across a spectrum of diseases today announced a global license agreement with Roche and Genentech a member of the Roche Gro...
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
Wednesday, August 03, 2022InterVenn Biosciences a clinical technology company leveraging glycoproteomics to transform the future of healthcare today announced the start of enrollment in its prospective cohort study for early detection of colorectal cancer and adenomas This co...
